A phase II trial of sorafenib (SO) in advanced chordoma patients (pt). This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a full text component.
As a researcher who has used a wide variety of methodologies, I understand the importance of acknowledging that we, as researchers, do not pick the methodology; rather, the research question dictates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results